mRNA / LNP CDMOs — Ranked by Signal Score
45
CDMOs tracked
36
Fully scored
17
With FDA records
47
FDA inspections
169
EMA/MHRA GMP certs
2
Warning letters
mRNA and lipid nanoparticle (LNP) manufacturing scaled rapidly after COVID-19 vaccines and now supports therapeutics across rare disease, oncology, and infectious disease. The platform pairs IVT mRNA synthesis with LNP formulation — two distinct capability sets.
Choosing an mRNA/LNP CDMO depends on IVT scale, template strategy (linearized plasmid vs PCR), LNP formulation and microfluidics, and cold-chain handling. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.
FDA inspection outcomes across these CDMOs: 19 NAI (no action), 25 VAI (voluntary action), 3 OAI (official action). Leading inspection & GMP sites: United States (44), Germany (35), Italy (27), UNITED KINGDOM (21), Denmark (17).
Last updated 2026-07-04. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
| # | CDMO | Signal Score | Quality | FDA · GMP | Capacity | Programs |
|---|---|---|---|---|---|---|
| 1 |
PC
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
|
91.5 | 100.0 | 4 insp · 17 GMP | — | 363 programs |
| 2 |
RP
ReciBioPharm
Keele, UK · Sodertalje, SE
|
88.0 | 100.0 | 0 insp · 3 GMP | — | 0 programs |
| 3 |
AE
Aldevron
Fargo, ND
|
85.3 | 100.0 | 1 insp · 0 GMP | — | 0 programs |
| 4 |
BNT
BioNTech (Mfg Services)
Mainz, DE · Marburg, DE
|
84.8 | 100.0 | 0 insp · 8 GMP | — | 24 programs |
| 5 |
FD
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
|
83.5 | 100.0 | 0 insp · 20 GMP | 0 programs | |
| 6 |
CD
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
|
82.5 | 99.7 | 2 insp · 9 GMP | — | 0 programs |
| 7 |
MR
Moderna (Contract Mfg)
Norwood, MA
|
81.8 | 100.0 | 2 insp · 3 GMP | — | 10 programs |
| 8 |
MK
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
|
81.8 | 98.6 | 2 insp · 2 GMP | — | 22 programs |
| 9 |
WK
Wacker Biotech
Jena, DE · Amsterdam, NL · San Diego, CA
|
81.6 | 100.0 | 0 insp · 13 GMP | — | 0 programs |
| 10 |
DH
Danaher (CGT Portfolio)
Washington, DC
|
81.5 | — | — | — | 0 programs |
| 11 |
EK
Evonik Health Care
Birmingham, AL · Vancouver, BC
|
81.5 | 99.8 | 2 insp · 2 GMP | — | 0 programs |
| 12 |
ND
Nitto Denko Avecia
Milford, MA
|
80.3 | 100.0 | 2 insp · 0 GMP | — | 0 programs |
| 13 |
KE
Kaneka Eurogentec
Seraing, BE
|
80.3 | 100.0 | 0 insp · 4 GMP | — | 0 programs |
| 14 |
CRA
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
|
79.4 | 99.9 | 2 insp · 16 GMP | — | 0 programs |
| 15 |
Lonza
Basel, Switzerland
|
78.2 | 95.1 | 2 insp · 8 GMP | — | 1 programs |
| 16 |
CC
CCRM
Toronto, ON
|
78.1 | 100.0 | 5 insp · 0 GMP | — | 0 programs |
| 17 |
PBI
ProBio
Taipei, TW
|
78.1 | 100.0 | 0 insp · 9 GMP | — | 0 programs |
| 18 |
Catalent
Bagsværd, Denmark (operating under Novo Holdings)
|
76.5 | 79.3 | 10 insp · 32 GMP | — | 0 programs |
| 19 |
CVC
CureVac (CDMO Services)
Tubingen, DE
|
75.3 | 100.0 | 0 insp · 7 GMP | — | 4 programs |
| 20 |
CA
Catalent (Novo Holdings)
Harmans, MD · Gosselies, BE
|
75.1 | 79.3 | 1 insp · 0 GMP | Available | 0 programs |
| 21 |
CG
Cytiva (Mfg Services)
Marlborough, MA · Uppsala, SE
|
74.0 | — | — | — | 0 programs |
| 22 |
NR
National Resilience
San Diego, CA · Boston, MA · RTP, NC · Philadelphia, PA
|
73.4 | 97.7 | 1 insp · 0 GMP | Available | 9 programs |
| 23 |
LZ
Lonza Biologics
Houston, TX · Portsmouth, NH · Geleen, NL · Basel, CH
|
72.8 | 95.1 | 1 insp · 0 GMP | Limited | 0 programs |
| 24 |
SP
ST Pharm
Seoul, KR
|
72.8 | 88.1 | 2 insp · 4 GMP | — | 0 programs |
| 25 |
TL
TriLink BioTechnologies
San Diego, CA
|
71.0 | — | — | — | 0 programs |
| 26 |
PN
Precision NanoSystems (Cytiva)
Vancouver, BC, Canada
|
69.0 | — | — | — | 0 programs |
| 27 |
SB
Samsung Biologics
Incheon, South Korea
|
68.5 | — | — | — | 0 programs |
| 28 |
BP
BSP Pharmaceuticals
Latina, Italy
|
67.6 | 77.4 | 7 insp · 12 GMP | — | 0 programs |
| 29 |
AT
Arcturus Therapeutics (Mfg)
San Diego, CA
|
65.5 | — | — | — | 0 programs |
| 30 |
UM
MassBiologics
Boston, MA
|
63.0 | — | 1 insp · 0 GMP | — | 0 programs |
| 31 |
HP
HIPRA Biotech Services
Amer, ES
|
63.0 | — | — | — | 0 programs |
| 32 |
CoJourney Inc.
Ambler, PA (US operations; primary manufacturing in Hangzhou, Zhejiang, China)
|
60.0 | — | — | Limited | 0 programs |
| 33 |
AC
Acuitas Therapeutics
Vancouver, BC
|
59.0 | — | — | — | 0 programs |
| 34 |
RR
RiboBio
Guangzhou, CN
|
59.0 | — | — | — | 0 programs |
| 35 |
QB
Quantoom Biosciences
Gosselies, BE
|
56.5 | — | — | — | 0 programs |
| 36 |
EH
Ethris
Planegg, DE
|
56.5 | — | — | — | 0 programs |
| — |
BioCina
Adelaide, Australia
|
Profiled | — | — | — | 0 programs |
| — |
ARCALIS, Inc.
Minamisoma, Fukushima, Japan
|
Profiled | — | — | — | 0 programs |
| — |
Roche / Genentech (Internal Manufacturing & CustomBiotech)
Basel, Switzerland
|
Profiled | — | — | — | 0 programs |
| — |
PCI Pharma Services
Philadelphia, PA
|
Profiled | — | — | — | 0 programs |
| — |
53Biologics
Boecillo, Valladolid, Spain
|
Profiled | — | — | — | 0 programs |
| — |
Centillion Technology Limited
Newcastle upon Tyne, United Kingdom
|
Profiled | — | — | — | 0 programs |
| — |
Porton Advanced
Cranbury, NJ (US HQ); GMP manufacturing sites in Suzhou, China
|
Profiled | — | — | — | 0 programs |
| — |
Sai Life Sciences
Hyderabad, India
|
Profiled | — | — | — | 0 programs |
| — |
Ardena
Ghent, Belgium
|
Profiled | — | — | — | 0 programs |
What to evaluate in a mRNA / LNP CDMO
IVT mRNA synthesis
Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost.
LNP formulation
LNP encapsulation via microfluidics determines potency and tolerability. Confirm lipid sourcing, formulation freedom-to-operate, and particle-size control.
Plasmid / starting material
mRNA needs a DNA template. Check whether the CDMO supplies GMP plasmid in-house or coordinates a plasmid CDMO — it affects timelines.
Cold chain & stability
mRNA-LNP products are temperature-sensitive. Evaluate frozen storage, fill-finish, and the stability program.
mRNA / LNP CDMOs — Frequently Asked Questions
Who are the top mRNA / LNP CDMOs?
By CDMO Signal's independent Signal Score, the top-ranked mRNA / LNP CDMOs include Pfizer CentreOne, ReciBioPharm, Aldevron. See the full ranked table above — scored on FDA, clinical, financial, and capacity data.
How many mRNA / LNP CDMOs have FDA inspection records?
CDMO Signal tracks 17 mRNA / LNP CDMOs with FDA inspection records and 169 EMA/MHRA GMP certificates across the group.
What should I look for in an mRNA / LNP CDMO?
Look for proven IVT mRNA synthesis at your scale, LNP formulation via microfluidics, a clear template/plasmid supply strategy, cold-chain capability, and a clean FDA and EMA/MHRA record.
Do mRNA CDMOs also make the LNP and plasmid?
Capabilities vary. Some CDMOs offer end-to-end IVT mRNA, LNP formulation, and GMP plasmid; others specialize in one step and coordinate partners. Check each profile's modality coverage above.
Related modalities
Other Modalities